AEDG raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-06-16 and is reviewed periodically as new material appears.
Identity is normally established by reversed-phase high-performance liquid chromatography combined with mass spectrometry, a pairing that separates components and confirms molecular mass at once. Purity is quoted as a percentage from the chromatogram, and figures above ninety-five percent are a frequent commercial specification. Amino acid analysis or sequencing supplies further confirmation when required. Because many short peptides behave similarly under chromatography, retention time alone does not establish sequence; the mass measurement is what separates one tetrapeptide from another, and certificates should report both.
Short peptides such as AEDG are normally supplied as a freeze-dried solid and are kept dry, cold, and shielded from light. Holding at minus twenty degrees Celsius is common for the long term, while a refrigerator suffices for brief periods before use. The material takes up moisture to some degree, so containers should stay sealed and be allowed to reach room temperature before opening, which limits condensation on the contents. Repeated warming and cooling of a single container is discouraged because it admits water and can lower the amount of intact peptide.
Dissolution is usually performed in water or a suitable aqueous buffer, and the resulting liquid is divided into single-use portions before freezing. Freeze-thaw cycling is a recognised source of loss for short peptides, since each cycle can encourage aggregation or adsorption onto container walls. Working solutions are generally kept cold and used within a short window, although published stability data specific to epitalon are thin. Containers should be marked with concentration and date, and solutions examined for cloudiness before use.
Laboratory work has examined effects on telomerase activity in cultured cells, on melatonin rhythms in animals, and on markers of oxidative stress. Some experiments report measurable changes while others show none, and the reported findings rest largely on small studies. The absence of large independent trials means the generality of these results is unresolved rather than settled. Review articles occasionally apply the label geroprotector, a term that reflects a research hypothesis about ageing rather than an established clinical finding.
Epitalon is the common name for a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, usually abbreviated AEDG. All four residues are proteinogenic amino acids, and the free peptide has a calculated mass near 390 grams per mole. Because the chain is short and carries no modifications, it is assembled readily by solid-phase synthesis and is distributed mainly as a freeze-dried solid for laboratory work. Catalogue listings use the spellings epitalon, epithalone, and simply AEDG, and the three refer to the same sequence.
| Property | Value | Notes |
|---|---|---|
| Sequence | Ala-Glu-Asp-Gly | Written in three-letter amino acid code |
| Single-letter code | AEDG | Form used in most catalogue entries |
| Typical purity specification | 95 percent or higher | Value read from the HPLC chromatogram |
| Storage, dry solid | Minus 20 degrees Celsius, desiccated | Sealed container, protected from light |
| Handling, solution | Divide into single-use portions | Limits losses from freeze-thaw cycling |
Identity and purity are established with reversed-phase high-performance liquid chromatography and mass spectrometry. The chromatogram shows the main peak and any truncated or oxidised by-products, while the mass spectrum confirms the expected 390 dalton mass. Amino acid analysis can corroborate composition when a sample's origin is uncertain. Counterion content, particularly residual trifluoroacetate from purification, is frequently reported alongside purity because it shifts the net mass of the solid.
Reference material is normally supplied as a lyophilised powder in a sealed vial. Product literature typically recommends storage at minus twenty degrees Celsius or colder, protected from light and moisture. Freeze-thaw cycling is usually avoided because repeated condensation can introduce water into the vial. Working solutions are commonly prepared fresh, aliquoted, and kept cold for short periods rather than stored at ambient temperature. Labelling the date of opening helps track how long a vial has been in use.
Solubility is high in water, phosphate-buffered saline and normal saline, a pattern that follows from the two acidic residues in the chain. The peptide dissolves poorly in non-polar solvents such as hexane or chloroform. Stock solutions are often prepared in water first and then diluted into the buffer of interest. Because the molecule is small and hydrophilic, filtration through a low-protein-binding membrane is usually straightforward, and visible particulates are uncommon in freshly made solutions.
The compound is generally described as a synthetic analogue of a fragment isolated from a pineal gland extract. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology introduced it during the 1980s and 1990s while studying short peptides from animal tissue. The original extract, called epithalamin, is a heterogeneous mixture, whereas epitalon is a single defined sequence. That distinction matters because findings reported for the extract are not automatically findings about the pure tetrapeptide, and claims about broader biological effects remain a separate question from the chemical identity described here.
Residue composition is the property that most cleanly separates verified material from mislabelled samples. Alanine, glutamate, aspartate and glycine appear in that order from the N-terminus, and the two acidic residues sit in the middle of the chain. Because the peptide is short, it can be produced by solid-phase synthesis and characterised by mass spectrometry without ambiguity. Any reported sample whose measured mass departs substantially from 390 daltons is a different compound or a degraded mixture rather than epitalon.
Epitalon is a synthetic tetrapeptide whose four residues are alanine, glutamate, aspartate and glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9 and its monoisotopic mass is near 390.35 daltons. The peptide carries two acidic side chains, so it is neutral to negatively charged in most aqueous buffers. Published reference summaries usually list it under both spellings, epitalon and epithalon, and treat the two names as the same material.
===== MeSH D08.811.682.690 – oxygenases ===== MeSH D08.811.682.690.416 – dioxygenases MeSH D08.811.682.690.416.277 – catechol 1,2-dioxygenase MeSH D08.811.682.690.416.305 – catechol 2,3-dioxygenase MeSH D08.811.682.690.416.319 – cysteine dioxygenase MeSH D08.811.682.690.416.326 – homogentisate 1,2-dioxygenase MeSH D08.811.682.690.416.328 – 3-hydroxyanthranilate 3,4-dioxygenase MeSH D08.811.682.690.416.330 – 4-hydroxyphenylpyruvate dioxygenase MeSH D08.811.682.690.416.333 – indoleamine-pyrrole 2,3-dioxygenase MeSH D08.811.682.690.416.444 – lipoxygenase MeSH D08.811.682.690.416.444.050 – arachidonate lipoxygenases MeSH D08.811.682.690.416.444.050.055 – arachidonate 5-lipoxygenase MeSH D08.811.682.690.416.444.050.060 – arachidonate 12-lipoxygenase MeSH D08.811.682.690.416.444.050.065 – arachidonate 15-lipoxygenase MeSH D08.811.682.690.416.444.525 – protocatechuate 3,4-dioxygenase MeSH D08.811.682.690.416.722 – tryptophan oxygenase MeSH D08.811.682.690.562 – inositol oxygenase MeSH D08.811.682.690.708 – mixed function oxygenases MeSH D08.811.682.690.708.062 – benzoate 4-monooxygenase MeSH D08.811.682.690.708.125 – catechol oxidase MeSH D08.811.682.690.708.125.500 – monophenol monooxygenase MeSH D08.811.682.690.708.170 – cytochrome p-450 enzyme system MeSH D08.811.682.690.708.170.040 – aryl hydrocarbon hydroxylases MeSH D08.811.682.690.708.170.040.024 – 7-alkoxycoumarin o-dealkylase MeSH D08.811.682.690.708.170.040.050 – aniline hydroxylase MeSH D08.811.682.690.708.170.040.110 – benzopyrene hydroxylase MeSH D08.811.682.690.708.170.040.332 – cytochrome p-450 cyp1a1 MeSH D08.811.682.690.708.170.040.443 – cytochrome p-450 cyp1a2 MeSH D08.811.682.690.708.170.040.499 – cytochrome p-450 cyp2b1 MeSH D08.811.682.690.708.170.040.555 – cytochrome p-450 cyp2d6 MeSH D08.811.682.690.708.170.040.777 – cytochrome p-450 cyp2e1 MeSH D08.811.682.690.708.170.040.888 – cytochrome p-450 cyp3a MeSH D08.811.682.690.708.170.085 – camphor 5-monooxygenase MeSH D08.811.682.690.708.170.500 – alkane 1-monooxygenase MeSH D08.811.682.690.708.170.915 – steroid hydroxylases MeSH D08.811.682.690.708.170.915.050 – aldosterone synthase MeSH D08.811.682.690.708.170.915.099 – aromatase MeSH D08.811.682.690.708.170.915.200 – cholesterol 7 alpha-hydroxylase MeSH D08.811.682.690.708.170.915.212 – cholesterol side-chain cleavage enzyme MeSH D08.811.682.690.708.170.915.400 – 25-hydroxyvitamin d3 1-alpha-hydroxylase MeSH D08.811.682.690.708.170.915.720 – steroid 11-beta-hydroxylase MeSH D08.811.682.690.708.170.915.730 – steroid 12-alpha-hydroxylase MeSH D08.811.682.690.708.170.915.737 – steroid 16-alpha-hydroxylase MeSH D08.811.682.690.708.170.915.748 – steroid 17-alpha-hydroxylase MeSH D08.811.682.690.708.170.915.760 – steroid 21-hydroxylase MeSH D08.811.682.690.708.292 – dopamine beta-hydroxylase MeSH D08.811.682.690.708.392 – fatty acid desaturases MeSH D08.811.682.690.708.392.312 – beta-carotene 15,15'-monooxygenase MeSH D08.811.682.690.708.392.468 – Linoleoyl-CoA desaturase MeSH D08.811.682.690.708.392.625 – stearoyl-coa desaturase MeSH D08.811.682.690.708.401 – gamma-butyrobetaine dioxygenase MeSH D08.811.682.690.708.410 – heme oxygenase (decyclizing) MeSH D08.811.682.690.708.410.500 – heme oxygenase-1 MeSH D08.811.682.690.708.425 – 4-hydroxybenzoate 3-monooxygenase MeSH D08.811.682.690.708.557 – kynurenine 3-monooxygenase MeSH D08.811.682.690.708.601 – phenylalanine hydroxylase MeSH D08.811.682.690.708.660 – procollagen-lysine, 2-oxoglutarate 5-dioxygenase MeSH D08.811.682.690.708.673 – procollagen-proline dioxygenase MeSH D08.811.682.690.708.715 – prostaglandin-endoperoxide synthases MeSH D08.811.682.690.708.749 – squalene monooxygenase MeSH D08.811.682.690.708.783 – steroid hydroxylases MeSH D08.811.682.690.708.783.050 – aldosterone synthase MeSH D08.811.682.690.708.783.099 – aromatase MeSH D08.811.682.690.708.783.200 – cholesterol 7 alpha-hydroxylase MeSH D08.811.682.690.708.783.212 – cholesterol side-chain cleavage enzyme MeSH D08.811.682.690.708.783.400 – 25-hydroxyvitamin d3 1-alpha-hydroxylase MeSH D08.811.682.690.708.783.720 – steroid 11-beta-hydroxylase MeSH D08.811.682.690.708.783.730 – steroid 12-alpha-hydroxylase MeSH D08.811.682.690.708.783.737 – steroid 16-alpha-hydroxylase MeSH D08.811.682.690.708.783.745 – steroid 17-alpha-hydroxylase MeSH D08.811.682.690.708.783.760 – steroid 21-hydroxylase MeSH D08.811.682.690.708.826 – trans-cinnamate 4-monooxygenase MeSH D08.811.682.690.708.870 – tryptophan hydroxylase MeSH D08.811.682.690.708.923 – tyrosine 3-monooxygenase
=== Angle restraints === In addition to distance restraints, restraints on the torsion angles of the chemical bonds, typically the psi and phi angles, can be generated. One approach is to use the Karplus equation, to generate angle restraints from coupling constants. Another approach uses the chemical shifts to generate angle restraints. Both methods use the fact that the geometry around the alpha carbon affects the coupling constants and chemical shifts, so given the coupling constants or the chemical shifts, a qualified guess can be made about the torsion angles.
== Colors and materials == Conventional LEDs are made from a variety of inorganic semiconductor materials. The following table shows the available colors with wavelength range, voltage drop and material:
Silver - Bar Gary William Adams, , Gatekeeper, Crown Estate, Windsor. Andrew John Buckland, , Jersey Herdsman, Royal Farms, Windsor. Neil Hepple Dodds, , Team Supervisor, Crown Estate, Windsor. Jose Manuel Lazarczuk, , Groundsman, Crown Estate Windsor. Silver Andrew David Basson, Office Assistant and Insignia Clerk, Royal Household. Gary Clarke, Fire Safety and Access Officer, Buckingham Palace. Edward Peter Evans, lately Divisional Sergeant Major, The King's Body Guard of the Yeomen of the Guard. Malcolm Greenland, Castle Attendant, Windsor Castle. Helen Hitchcock, lately Coffee Shop Supervisor, Windsor Farm Shop. Isabel Lorna Laylo, Housekeeping Assistant, Kensington Palace. Matthew Simon Murphy, Senior Palace Attendant, Royal Household. Timothy James Rayson, Axe Keeper, The Honourable Corps of Gentlemen at Arms. Elisabeth Michelle Roberts, Helpdesk and Property Co-ordinator, Windsor Castle. Corporal of the Horse Kate Elizabeth Sandford, Royal Corps of Army Music, 30186649; Household Cavalry Band, on the occasion of the Coronation of Their Majesties The King and The Queen. James Richard Shaw, lately Personal Assistant to the Assistant Private Secretary to His Majesty The King. Fiona Ailsa Smith, lately Ranger, Balmoral Estate. John Sspelzini, Divisional Sergeant Major, The King's Body Guard of the Yeomen of the Guard. Monica Jane Tandy, Warden, Windsor Castle. Vanessa Anne Wakeford, House Manager, Government House, Guernsey. Barry James Whearty, Painter and Decorator, Crown Estate, Windsor.
As the complexity of proteolytic networks was uncovered, more thorough descriptions of the degradome and ways to study it became necessary. In 2007, Dr. Overall updated the field with a review co-authored by Dr. Carl Blobel detailing how advanced methods were revolutionizing protease-substrate discovery. They described the process of linking proteases to their substrates on a step by step process, beginning with biochemical and proteomic discovery, validation using cellular based assays, and progressing to whole organism levels using animal models. More recently, as technology and techniques have advanced, the Overall Lab and others have continued to direct the field using more powerful and quantitative techniques.
Sources: en.wikipedia.org
, the spreading slows down thus useful to set a prediction on the short-term trends. Also, it can be used to directly calculate the threshold population of vaccination/immunization for the herd immunity stage by setting
== Reception == American service members generally find UGRs to taste better than MREs. The UGR-E in particular was positively received, with the holiday menu singled out as "a morale booster" for soldiers otherwise unable to have proper Thanksgiving or Christmas dinners on deployment. However, some items—namely egg dishes, as reported by Stars and Stripes in 2005—are widely disliked due to poor taste. Some soldiers have also cautioned against mixing or switching between UGRs and MREs, which is said to cause constipation.
==== Microparticle and nanoparticle synthesis ==== Advanced particles and particle-based materials, such as polymer particles, microcapsules, nanocrystals, and photonic crystal clusters or beads can be synthesized with the assistance of droplet-based microfluidics. Nanoparticles, such as colloidal CdS and CdS/CdSe core-shell nanoparticles, can also be synthesized through multiple steps on a millisecond time scale in a microfluidic droplet-based system. Nanoparticles, microparticles and colloidal clusters in microfluidic devices are useful for functions such as drug delivery. The first particles incorporated in droplet-based systems were silica gels in the micrometer size range in order to test their applications in the manufacturing of displays and optical coatings. Mixing solid particles with aqueous microdroplets requires changes to microfluidic channels such as additional reagent mixes and choice of specific materials such as silica or polymers that do not interfere with the channels and any bioactive substances the droplets contain. The synthesis of copolymers requires milling macroscopic molecules to microparticles with porous, irregular surfaces using organic solvents and emulsification techniques. These droplets preloaded with microparticles can also be quickly processed using UV irradiation. Characterization of these microparticles and nanoparticles involves microimaging for analyzing the structure and the identification of the macroscopic material being milled.
== See also == Aroma compound Criteria air contaminants Fugitive emission Non-methane volatile organic compound Organic compound Trichloroethylene Vapor intrusion VOC contamination of groundwater Volatile Organic Compounds Protocol
A common criticism of both the PDCAAS and the DIAAS is that calculating the PDCAAS/DIAAS of a diet solely based on the PDCAAS/DIAAS of the individual constituents is misleading, because one food may provide an abundance of an amino acid that the other is missing, in which case the PDCAAS/DIAAS of the diet is higher than that of any one of the constituents. To arrive at the final result, all individual amino acids would have to be taken into account, so the protein quality of each constituent would be superfluous. For example, various cereals have protein qualities between 0.4 and 0.8 and are generally limited by lysine, but contain more than enough methionine. Legumes, with the exception of soy, generally have protein qualities between 0.5 and 0.8 and are limited by methionine rather than lysine. When eaten together in the optimal ratio, the quality of the combined constituent may be as high as 1.0, because each constituent's protein is complemented by the other. A more extreme example would be the combination of gelatine (which contains virtually no tryptophan and thus has a PDCAAS close to 0) with isolated tryptophan (which, lacking all other essential amino acids, also has a PDCAAS of 0). Despite individual scores of 0, the combination of both in adequate amounts has a positive PDCAAS, with the limiting amino acids isoleucine, threonine, and methionine.
Sources: en.wikipedia.org
Reversed-phase high-performance liquid chromatography is run alongside mass spectrometry. The chromatogram separates components and gives a purity figure, while the mass spectrum confirms that the measured molecular mass matches the expected sequence. Neither measurement on its own is treated as sufficient.
Long-term holding is usually at minus twenty degrees Celsius in a sealed, desiccated container. A refrigerator is adequate for short intervals before use. Light exposure is normally avoided as well. Allowing a cold container to warm before opening reduces moisture condensation on the contents.
Repeated cycles are generally avoided. Each freeze and thaw can promote aggregation or loss of peptide to container surfaces, which reduces the amount available for later work. Dividing a solution into single-use portions at the outset is the usual way to limit this problem.
It is a four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine. The chain is unmodified and contains only standard proteinogenic residues, which makes it straightforward to produce by solid-phase synthesis and to characterise by standard peptide methods.